Michael D. Schneider
Direktor/Vorstandsmitglied bei The Medical Research Council
Profil
Michael D.
Schneider was the founder of Kardia Therapeutics, Inc. founded in 2002, where he held the title of Director from 2002 to 2010.
Currently, he is a Director at The Medical Research Council.
Previously, he held the position of Director-Centre for Research Excellence at British Heart Foundation, was a Professor at Baylor College of Medicine from 1984 to 2010, and was the Head-Cardiovascular Science at The National Heart & Lung Institute.
Dr. Schneider earned his doctorate degree from the University of Pennsylvania in 1976.
Aktive Positionen von Michael D. Schneider
| Unternehmen | Position | Beginn |
|---|---|---|
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Direktor/Vorstandsmitglied | 12.07.2011 |
Ehemalige bekannte Positionen von Michael D. Schneider
| Unternehmen | Position | Ende |
|---|---|---|
| British Heart Foundation | Corporate Officer/Principal | - |
| Baylor College of Medicine | Corporate Officer/Principal | - |
The National Heart & Lung Institute
 The National Heart & Lung Institute Miscellaneous Commercial ServicesCommercial Services The National Heart & Lung Institute provided medical educational services. The company was headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Kardia Therapeutics, Inc.
 Kardia Therapeutics, Inc. BiotechnologyHealth Technology Kardia Therapeutics, Inc. develops cardiac regenerative therapies. It focuses in the areas of myocardial infarction and heart failure. The firm's portfolio of technologies utilizes three related approaches which include adult cardiac progenitor cells, stem cell optimization technologies, and homing/growth factor therapies. The company was founded by Michael D. Schneider and Robert J. Schwartz in 2002 and is headquartered in Houston, TX. | Gründer | - |
Ausbildung von Michael D. Schneider
| University of Pennsylvania | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
| British Heart Foundation | Commercial Services |
Kardia Therapeutics, Inc.
Kardia Therapeutics, Inc. BiotechnologyHealth Technology Kardia Therapeutics, Inc. develops cardiac regenerative therapies. It focuses in the areas of myocardial infarction and heart failure. The firm's portfolio of technologies utilizes three related approaches which include adult cardiac progenitor cells, stem cell optimization technologies, and homing/growth factor therapies. The company was founded by Michael D. Schneider and Robert J. Schwartz in 2002 and is headquartered in Houston, TX. | Health Technology |
The National Heart & Lung Institute
The National Heart & Lung Institute Miscellaneous Commercial ServicesCommercial Services The National Heart & Lung Institute provided medical educational services. The company was headquartered in London, the United Kingdom. | Commercial Services |
